Research output per year
Research output per year
Personal profile
Headline
ASSISTANT PROFESSOR | Medicine, Gastroenterology
Fingerprint
Dive into the research topics where Ryan Ungaro is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Anti-Integrin αvβ6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis
CCC-GEM Project Research Consortium & OSCCAR Consortium, Apr 2023, In: Gastroenterology. 164, 4, p. 619-629 11 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Association of C-reactive Protein and Partial Mayo Score With Response to Tofacitinib Induction Therapy: Results From the Ulcerative Colitis Clinical Program
Dubinsky, M. C., Magro, F., Steinwurz, F., Hudesman, D. P., Kinnucan, J. A., Ungaro, R. C., Neurath, M. F., Kulisek, N., Paulissen, J., Su, C., Ponce De Leon, D. & Regueiro, M., 1 Jan 2023, In: Inflammatory Bowel Diseases. 29, 1, p. 51-61 11 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Scopus citations -
Besting the Biologics: Vancomycin Monotherapy for Ulcerative Colitis Management in Patients with Primary Sclerosing Cholangitis
Ahmed, T., Kayal, M., Hashem, D. & Ungaro, R. C., Apr 2023, In: Digestive Diseases and Sciences. 68, 4, p. 1118-1120 3 p.Research output: Contribution to journal › Article › peer-review
-
Biopsy and blood-based molecular biomarker of inflammation in IBD
Argmann, C., Hou, R., Ungaro, R. C., Irizar, H., Al-Taie, Z., Huang, R., Kosoy, R., Venkat, S., Song, W. M., Di'narzo, A. F., Losic, B., Hao, K., Peters, L., Comella, P. H., Wei, G., Atreja, A., Mahajan, M., Iuga, A., Desai, P. T., Branigan, P., & 15 others, 1 Jul 2023, In: Gut. 72, 7, p. 1271-1287 17 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations -
Comparative Safety of Biologic Agents in Patients With Inflammatory Bowel Disease With Active or Recent Malignancy: A Multi-Center Cohort Study
Rising Educators Academics and Clinicians Helping-IBD (REACH-IBD), Jun 2023, In: Clinical Gastroenterology and Hepatology. 21, 6, p. 1598-1606.e5Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations
Press/Media
-
Concomitant 5-ASA treatment does not affect efficacy, safety of vedolizumab in IBD
17/08/23
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Researcher Has Provided New Study Findings on Inflammatory Bowel Disease (Early Biologic Treatment Decreases Risk of Surgery in Crohn's Disease but not in Ulcerative Colitis: Systematic Review and ...)
Ryan Ungaro & Jean-Frédéric Colombel
14/08/23
1 item of Media coverage
Press/Media
-
Icahn School of Medicine at Mount Sinai Researcher Reports Recent Findings in COVID-19 (Managing IBD in the COVID-19 era)
30/06/23
1 item of Media coverage
Press/Media
-
Studies from Icahn School of Medicine at Mount Sinai in the Area of Ulcerative Colitis Described (Anti-integrin Avb6 Autoantibodies Are a Novel Biomarker That Antedate Ulcerative Colitis)
Sacha Gnjatic, Saurabh Mehandru, Ryan Ungaro, Manasi Agrawal, Bruce E. Sands, Francesca Petralia & Jean-Frédéric Colombel
5/05/23
1 item of Media coverage
Press/Media